Researchers Tripping Out on Mushrooms as Gambling Cure

Using a derivative of magic mushrooms has been promoted as a cure for several addictions, including gambling, and now researchers at the University of Miami, Ohio are showing promising results.

Researchers Tripping Out on Mushrooms as Gambling Cure A growing body of research suggests psychedelic mushrooms may have therapeutic benefits for certain conditions. Now a movement seeks to decriminalize them.

A psilocybin-based drug is showing effectiveness in altering negative behavior in laboratory rodents, and could be a key to treating problem gambling.

Researchers across the country are using the drug associated with magic mushrooms, a popular psychedelic drug, for several types of addiction, including drinking, smoking, and gambling.

Arizona lawmakers recently introduced a bill to fund a $30 million grant to explore the benefits of psilocybin in regard to treating abuse and addiction disorders, including gambling.

In Ohio, researchers at Miami University have set up a lab that simulates a casino, complete with flashing lights and casino sounds, to see if they can simulate a problem gambler, according to a story in Sports Handle. 

A former state senator helped the university get funding to create  Miami’s Institute for Responsible Gaming, Lotteries, and Sport two years ago. The goal was to see the connection between psilocybin and treating addictive gambling.

Lead psychologist Dr. Matthew McMurray and his team give the rats two choices: the first is to choose a lever and get a treat every time. The second is to touch another lever and get three treats sometimes and other times nothing.

McMurray uses two sets of rats—some that are healthy and others that are put in stressful situations for two weeks. They found that the healthy rats opt for the first lever, while the stressed-out rats tend to hit the second lever more consistently.

“If we expose those rats to chronic stress, we see their decision-making gets bad. They prefer the risky option regardless of its probability, just like a gambling addict,” McMurray told Sports Handle. “When we treat those stressed animals with psilocybin, their decision making gets much better.”

McMurray plans to publish a paper reporting on the results.

The idea of psilocybin as a treatment is not new. A 2016 story in Psychedelic Times explored the link between mind altering medicine and addiction, including gambling. The story concluded that it is indeed effective.

Now, however, it may be a matter of months before the theory is translated into human trials.

“We need companies to take drugs into this new marketplace, especially with the psilocybin-based therapies,” McMurray said. “Depending on the level of corporate involvement, it could be anywhere from a year to 20 years. I really have no idea. But we need new forms of treatment for this very complex disease.”

Articles by Author: Roger Gros

Roger Gros is publisher of Global Gaming Business, the industry’s leading gaming trade publication, and all its related publications. Prior to joining Global Gaming Business, Gros was president of Inlet Communications, an independent consulting firm. He was vice president of Casino Journal Publishing Group from 1984-2000, and held virtually every editorial title during his tenure. Gros was editor of Casino Journal, the National Gaming Summary and the Atlantic City Insider, and was the founding editor of Casino Player magazine. He was a co-founder of the American Gaming Summit and the Southern Gaming Summit conferences and trade shows.
Roger Gros is the author of the best-selling book, "How to Win at Casino Gambling" (Carlton Books, 1995), now in its fourth edition. Gros was named “Businessman of the Year” for 1998 by the Greater Atlantic City Chamber of Commerce and received the Lifetime Achievement Award from the American Gaming Association in 2012 as part of the annual AGA Communications Awards.

**GGBNews.com is part of the Clarion Events Group of companies (Clarion). We take your privacy seriously. By registering for this newsletter we wish to use your information on the basis of our legitimate interests to keep in contact with you about other relevant events, products and services which may be of interest to you. We will only ever use the information we collect or receive about you in accordance with our Privacy Policy. You may manage your preferences or unsubscribe at any time using the link in our emails.